The 2026 International Kidney Cancer Symposium (IKCS): North America, organized by the Kidney Cancer Association, will take place on 19–21 November 2026 at the Renaissance Dallas Hotel in Dallas, Texas.

The multidisciplinary meeting is expected to bring together more than 300 participants and over 50 international kidney cancer experts, including physicians, researchers, advocates, and industry partners. The programme will explore clinical and translational advances in renal cell carcinoma, including emerging therapeutic targets, targeted protein degradation, biomarkers in the immunotherapy era, modern local treatment, real-world evidence, artificial intelligence, treatment escalation and de-escalation, and future therapeutic strategies.

Meeting features will include expert scientific sessions, a surgical workshop, keynote and oral abstract presentations, posters, guided poster tours, exhibitions, mentorship and young-investigator activities, awards, and networking events. Abstract submissions close on 28 August 2026, while the early-registration deadline is 29 October 2026.